Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business Practice

Business & Regulation Business Practice

Biosimilars’ 2020 Breakthrough?

| Stephanie Sutton

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

Business & Regulation COVID-19

The Pandemic Diaries

How is the business of making medicine changing in light of the COVID-19 pandemic?

Business & Regulation Business Practice

Creating Value at All Levels

| Maryam Mahdi

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

Business & Regulation Business Practice

If You Build It, They Will Come

| Maryam Mahdi

Sitting Down With... Kelly Chibale, Director, H3D, University of Cape Town, South Africa.

Business & Regulation Business Practice

When the Worst Happens

| Stephanie Sutton

Business insurance exists to help companies when unexpected events and damages occur – so you need to have the right policy in place.

Business & Regulation Business Practice

The Great Rebrander

| Maryam Mahdi

What makes pharma so good at rebranding?

Business & Regulation Business Practice

Continued Education

| Maryam Mahdi

Pfizer is supporting homelearners amid the COVID-19 pandemic.

Manufacture COVID-19

Biopharma Banding Together

| Bill Jarvis

How has the COVID-19 pandemic changed the industry? And how can we respond faster next time?

Business & Regulation Business Practice

Making Money Through M&As

| George Chressanthis, Aditya Bhandari, Rashi Thaper

Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?

Business & Regulation Business Practice

The Pandemic Diaries

How is the business of making medicine changing in light of the COVID-19 pandemic?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register